Medical devices, healthcare technology and the business of care
510(k) clearance · K260053

Power Wheelchair (OS-R-M01I)

Beijing OrionStar Technology Co., Ltd. · Decision date Sep 8, 2026

MEDTECHLEDGER EXPLANATIONK260053

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on 2026-09-08 for Power Wheelchair (OS-R-M01I), submitted by Beijing OrionStar Technology Co., Ltd. of Beijing, CN, under 510(k) number K260053. The application was received on 01/08/2026 and reviewed by the Physical Medicine panel under regulation 890.3860, product code ITI, device classification name Wheelchair, Powered. It is listed as a traditional 510(k), not reviewed by a third party, not a combination product, and without an authorized predetermined change control plan.

SESE means FDA cleared the submission as substantially equivalent to a legally marketed predicate; it is not a PMA approval. The record identifies the subject device only as a power wheelchair and does not describe specific components, changed items, or the predicate device relied upon. The public page also gives no indications for use, no summary of safety and effectiveness data, and no review rationale, so the technical basis for the equivalence finding remains unknown from this source.

Shanghai SUNGO Management Consulting Co., Ltd. is listed as correspondent, with Shengnan Fang as applicant contact and Ariel Xiang as correspondent contact. The page was last updated 09/14/2026.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Physical Medicine
Decision date
Sep 8, 2026
FDA decision documents: 510(k) Premarket Notification

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K260053
Regulatory pathway
510(k) premarket notification
Product code
ITI
Decision code
SESE
Decision date
Sep 8, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Wheelchair, Powered.

Product code
ITI
FDA device class
2

FDA decision timeline

  1. K260053 received

    Application receipt date recorded by FDA.

  2. K260053 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code ITI

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Beijing OrionStar Technology Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Beijing

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records